Cardio-renal interaction: Impact of renal function and anemia on the outcome of chronic heart failure

Heart and Vessels

Volumn 25, Issue 4, 2010, Pages 306-312

  Kimura, Hisashi ^a   Hiramitsu, Shinya ^a   Miyagishima, Kenji ^a   Mori, Kazumasa ^a   Yoda, Ryuji ^a   Kato, Shigeru ^a   Kato, Yasuchika ^a   Morimoto, Shin Ichiro ^a   Hishida, Hitoshi ^a   Ozaki, Yukio ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anemia; Cardio renal anemia syndrome; Chronic heart failure; Chronic kidney disease; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; PHOSPHODIESTERASE III INHIBITOR; PIMOBENDAN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CALCULATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMOGLOBINS; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY DISEASES; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956053939     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1201-y     Document Type: Article

References (31)

1. A.S. Go J. Yang L.M. Ackerson K. Lepper S. Robbins B.M. Massie M.G. Shlipak 2006 Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) Study Circulation 113 2713 2723 10.1161/CIRCULATIONAHA.105.577577 16754803
2. S.J. Pocock D. Wang M.A. Pfeffer S. Yusuf J.J. McMurray K.B. Swedberg J. Östergren E.L. Michelson K.S. Pieper C.B. Granger 2006 Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 65 75 10.1093/eurheartj/ehi555 16219658
3. T.B. Horwich G.C. Fonarow M.A. Hamilton W.R. MacLellan J. Borenstein 2002 Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure J Am Coll Cardiol 39 1780 1786 10.1016/S0735-1097(02)01854-5 12039491
4. D. Silverberg D. Wexler M. Blum Y. Wollman A. Iaina 2003 The cardio-renal anemia syndrome: does it exist? Nephrol Dial Transplant Suppl 8 7 12
5. N. Shiba M. Matsuki J. Takahashi T. Tada J. Watanabe H. Shimokawa 2008 Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Implications of the CHART Study Circ J 72 173 178 10.1253/circj.72.173 18219149
6. M.J. Sarnak A.S. Levey A.C. Schoolwerth J. Coresh B. Culleton L.L. Hamm P.A. McCullough B.L. Kasiske E. Kelepouris M.J. Klag P. Parfrey M. Pfeffer L. Raij D.J. Spinosa P.W. Wilson 2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention Circulation 108 2154 2169 10.1161/01.CIR.0000095676.90936.80 14581387
7. T. Ninomiya Y. Kiyohara M. Kubo Y. Tanizaki Y. Doi K. Okubo Y. Wakugawa J. Hata Y. Oishi K. Shikata K. Yonemoto H. Hirakata M. Iida 2005 Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study Kidney Int 68 228 236 10.1111/j.1523-1755.2005.00397.x 15954912
8. A.S. Go G.M. Chertow D. Fan C.E. McCulloch C.Y. Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296 1305 10.1056/NEJMoa041031 15385656
9. E. Imai M. Horio K. Nitta K. Yamagata K. Iseki Y. Tsukamoto S. Ito H. Makino A. Hishida S. Matsuo 2007 Modification of the modification of diet in renal disease (MDRD) study equation for Japan Am J Kidney Dis 50 927 937 10.1053/j.ajkd.2007.09.004 18037093
10. E. Imai M. Horio K. Nitta K. Yamagata K. Iseki S. Hara N. Ura Y. Kiyohara H. Hirakata T. Watanabe T. Moriyama Y. Ando D. Inaguma I. Narita H. Iso K. Wakai Y. Yasuda Y. Tsukamoto S. Ito H. Makino A. Hishida S. Matsuo 2007 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease Clin Exp Nephrol 11 41 50 10.1007/s10157-006-0453-4 17384997
11. E. Imai M. Horio K. Iseki K. Yamagata T. Watanabe S. Hara N. Ura Y. Kiyohara H. Hirakata T. Moriyama Y. Ando K. Nitta D. Inaguma I. Narita H. Iso K. Wakai Y. Yasuda Y. Tsukamoto S. Ito H. Makino A. Hishida S. Matsuo 2007 Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient Clin Exp Nephrol 11 156 163 10.1007/s10157-007-0463-x 17593516
12. P.A. McKee W.P. Castelli P.M. McNamara W.B. Kannel 1971 The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1441 1446 10.1056/NEJM197112232852601 5122894
13. F.A. McAlister J. Ezekowitz M. Tonelli P.W. Armstrong 2004 Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 1004 1009 10.1161/01.CIR.0000116764. 53225.A9 14769700
14. C. Pitsavos G. Kourlaba D.B. Panagiotakos Y. Kogias Y. Mantas C. Chrysohoou C. Stefanadis 2007 Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: the GREECS study Circ J 71 9 14 10.1253/circj.71.9 17186971
15. K. Nakamura T. Okamura T. Hayakawa T. Kadowaki Y. Kita H. Ohnishi S. Saitoh K. Sakata A. Okayama H. Ueshima The NIPPON DATA90 research group 2006 Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90 Circ J 70 954 959 10.1253/circj.70.954 16864924
16. M. Senni M.M. Redfield 2001 Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 38 1277 1282 10.1016/S0735-1097(01)01567-4 11691495
17. M. Tsuchihashi H. Tsutsui K. Kodama F. Kasagi A. Takeshita 2000 Clinical characteristics and prognosis of hospitalized patients with congestive heart failure, a study in Fukuoka, Japan Circ J 64 953 959 10.1253/jcj.64.953
18. H. Tsutsui M. Tsuchihashi A. Takeshita 2001 Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function Am J Cardiol 88 530 533 10.1016/S0002-9149(01)01732- 5 11524063
19. T. Ogihara K. Nakao T. Fukui K. Fukiyama K. Ueshima K. Oba T. Sato T. Saruta for the Candesartan Antihypertensive Survival Evaluation in Japan trial group 2008 Effects of candesartan compared with amlodipine in hypertensive patients trial with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial Hypertension 51 393 398 10.1161/ HYPERTENSIONAHA.107.098475 18172059
20. J.P. Casas W. Chua S. Loukogeorgakis P. Vallance L. Smeeth A.D. Hingorani R.J. MacAllister 2005 Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis Lancet 366 2026 2033 10.1016/S0140-6736(05)67814-2 16338452
21. G.M. Felker W.A. Gattis J.D. Leimberger K.F. Adams M.S. Cuffe M. Gheorghiade C.M. O'Connor 2003 Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure Am J Cardiol 92 625 628 10.1016/S0002-9149(03)00740-9 12943893
22. G.M. Felker K.F. Adams Jr W.A. Gattis C.M. O'Connor 2004 Anemia as a risk factor and therapeutic target in heart failure J Am Coll Cardiol 44 959 966 10.1016/j.jacc.2004.05.070 15337204
23. D.S. Silverberg D. Wexler A. Iaina 2004 The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? J Nephrol 17 749 761 15593047
24. D.S. Silverberg D. Wexler B. Blum A. Iaina 2003 Anemia in chronic kidney disease and congestive heart failure Blood Purif 21 124 130 10.1159/000067856 12596758
25. A.J. Coats 2004 Anaemia and heart failure Heart 90 977 979 10.1136/hrt.2003.012997 15310675
26. D.S. Silverberg D. Wexler D. Sheps M. Blum G. Keren R. Baruch D. Schwartz T. Yachnin S. Steinbruch I. Shapira S. Laniado A. Iaina 2001 The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 37 1775 1780 10.1016/S0735-1097(01)01248-7 11401110
27. D.S. Silverberg D. Wexler M. Blum G. Keren D. Sheps E. Leibovitch D. Brosh S. Laniado D. Schwartz T. Yachnin I. Shapira D. Gavish R. Baruch B. Koifman C. Kaplan S. Steinbruch A. Iaina 2000 The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations J Am Coll Cardiol 35 1737 1744 10.1016/S0735-1097(00)00613-6 10841219
28. R. Berger M. Huelsman K. Strecker A. Bojic P. Moser B. Stanek R. Pacher 2002 B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2392 2397 10.1161/01.CIR.0000016642.15031.34 12021226
29. K. Maeda M.D. Maeda T. Tsutamoto A. Wada N. Mabuchi M. Hayashi T. Tsutsui M. Ohnishi M. Sawaki M. Fujii T. Matsumoto M. Kinoshita 2000 High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 1587 1593 10.1016/S0735-1097(00)00912-8 11079662
30. H. Ueno M. Nakayama S. Kojima K. Kusuhara Y. Nagayoshi M. Yamamuro T. Nishijima H. Usuku K. Kaikita H. Sumida H. Yamabe S. Sugiyama M. Yoshimura H. Ogawa 2008 The synergistic combined effect of anemia with high plasma levels of Btype natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events Heart Vessels 23 243 248 10.1007/s00380-007-1034-5 18649054
31. A. Karavidas G. Lazaros E. Matsakas D. Farmakis J. Parissis I.A. Paraskevaidis C. Michailidis D. Avramidis A. Zacharoulis S. Arapi A. Kaoukis A. Zacharoulis 2008 Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes Heart Vessels 23 181 186 10.1007/s00380-007-1022-9 18484161